STANDARD BIOTOOLS revenue breakdown overview

STANDARD BIOTOOLS revenue for the last year amounted to 159.00 M CHF, the most of which — 123.32 M CHF — came from its highest performing source at the moment, Proteomics, the year earlier bringing 53.79 M CHF. The greatest contribution to the revenue figure was made by United States — last year it brought STANDARD BIOTOOLS 81.65 M CHF, and the year before that — 37.13 M CHF.